Tirzepatide
Dual GIP/GLP-1 agonist for weight loss and blood sugar control. Clinically proven efficacy up to −22% of initial body weight.
Calorize — peptide protocol & nutrition tracker
This substance is approved by regulators as a medicine and is dispensed on prescription. The dose is chosen by a doctor. The calculator below converts a dose you have already been prescribed into syringe units — it does not replace a prescription.
Approved by the FDA and EMA (Mounjaro, Zepbound). Prescription-only.
Every figure on this page is a dose reported in published sources. It is reference information, not a recommendation and not a protocol to follow. Any decision about injecting is one to make with a doctor.
Medical disclaimerWhat is Tirzepatide?
Tirzepatide (brand names Mounjaro, Zepbound) is an injectable medication and the first-in-class dual GIP and GLP-1 receptor agonist. Unlike semaglutide, it activates two hormonal pathways, delivering more pronounced weight loss effects.
What follows is dosing arithmetic and numeric protocols drawn from published sources and clinical trials. It describes what those sources report; it is not medical advice and not instructions for use. This part of the page is meant for people aged 18 and over.
The confirmation is kept in this browser, and on the account for signed-in users. The peptide description and its regulatory status are available without it.
What follows is dosing arithmetic and numeric protocols drawn from published sources and clinical trials. It describes what those sources report; it is not medical advice and not instructions for use. This part of the page is meant for people aged 18 and over.
The confirmation is kept in this browser, and on the account for signed-in users. The peptide description and its regulatory status are available without it.
Rapid weight loss burns muscle along with fat — that is what sits behind Ozempic face. Enough protein is what separates the two.
Check Protein Norm